Headline vs. study: Predicting, preventing and other clickbait
Could finding more cancer lead us to understand risk factors less?
Podcast: Why a health care journalist chose active surveillance for prostate cancer
Why biotech celeb Craig Venter’s prostate cancer story should be read with healthy dose of skepticism
Overall impressive: News media coverage of NEJM study on treating vs not treating prostate cancer
Despite thumbs down from professional groups, mass prostate cancer screening events continue, often with misleading promotions
“Skyrocketing” prostate cancer? Journos, cool your jets
The patient as public relations tool: Why readers should be wary of single-anecdote news stories
“More accurate than traditional biopsies” and other misinformation about a new prostate cancer test from NY-Presbyterian Hospital
Sam’s Club serves up a Father’s Day prostate special. Such a deal!